154 related articles for article (PubMed ID: 18823375)
21. Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer.
Cao C; Albert JM; Geng L; Ivy PS; Sandler A; Johnson DH; Lu B
Cancer Res; 2006 Dec; 66(23):11409-15. PubMed ID: 17145887
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.
Zhang X; Cheung RM; Komaki R; Fang B; Chang JY
Clin Cancer Res; 2005 Sep; 11(18):6657-68. PubMed ID: 16166445
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma.
Kim MY; Shin JY; Kim JO; Son KH; Kim YS; Jung CK; Kang JH
BMC Cancer; 2020 Nov; 20(1):1057. PubMed ID: 33143663
[TBL] [Abstract][Full Text] [Related]
24. Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study.
Niho S; Hosomi Y; Okamoto H; Nihei K; Tanaka H; Hida T; Umemura S; Goto K; Akimoto T; Ohe Y
Jpn J Clin Oncol; 2019 Jul; 49(7):614-619. PubMed ID: 30916304
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature.
Lee HJ; Yoon C; Park DJ; Kim YJ; Schmidt B; Lee YJ; Tap WD; Eisinger-Mathason TS; Choy E; Kirsch DG; Simon MC; Yoon SS
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):621-30. PubMed ID: 25544668
[TBL] [Abstract][Full Text] [Related]
26. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine).
Kobayashi S; Fujino N; Suzuki S; Yanai M
Respirology; 2009 Jul; 14(5):771-2. PubMed ID: 19659655
[TBL] [Abstract][Full Text] [Related]
28. NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment.
Moon EJ; Sonveaux P; Porporato PE; Danhier P; Gallez B; Batinic-Haberle I; Nien YC; Schroeder T; Dewhirst MW
Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20477-82. PubMed ID: 21059928
[TBL] [Abstract][Full Text] [Related]
29. Preclinical analysis of the antitumor efficacy of TS-1 using human uterine cervical cancer tumor xenografts.
Nagai N; Komatsu M; Yunokawa M; Shiroyama Y; Hirata E
Oncol Rep; 2008 Nov; 20(5):1149-56. PubMed ID: 18949415
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
Zhu H; Zhang S
J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
[TBL] [Abstract][Full Text] [Related]
31. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.
Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X
Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766
[TBL] [Abstract][Full Text] [Related]
32. [A case of mandibular gingival cancer (T4) responding to concurrent chemoradiotherapy with TS-1].
Nakashiro K; Shintani S; Yano J; Shinohara Y; Terakado N; Hamakawa H
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1309-12. PubMed ID: 14518411
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models.
Albert JM; Cao C; Kim KW; Willey CD; Geng L; Xiao D; Wang H; Sandler A; Johnson DH; Colevas AD; Low J; Rothenberg ML; Lu B
Clin Cancer Res; 2007 May; 13(10):3033-42. PubMed ID: 17505006
[TBL] [Abstract][Full Text] [Related]
34. [A case of neck metastasis from hypopharyngeal carcinoma successfully treated with TS-1].
Kajikawa H; Nario K; Miyahara H
Gan To Kagaku Ryoho; 2004 Apr; 31(4):631-4. PubMed ID: 15114715
[TBL] [Abstract][Full Text] [Related]
35. Enhanced anticancer effect of the combination of BIBW2992 and thymidylate synthase-targeted agents in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor.
Takezawa K; Okamoto I; Tanizaki J; Kuwata K; Yamaguchi H; Fukuoka M; Nishio K; Nakagawa K
Mol Cancer Ther; 2010 Jun; 9(6):1647-56. PubMed ID: 20530710
[TBL] [Abstract][Full Text] [Related]
36. [Clinical efficacy of TS-1 in refractory bone recurrence of a postoperative squamous lung cancer patient].
Osaki T; Takimoto T; Furukawa M; Inoue M; Okumura M; Niju T; Kijima T; Kumagai T; Yoshida M; Tachibana I; Kawase I
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1119-23. PubMed ID: 16912531
[TBL] [Abstract][Full Text] [Related]
37. [A case of multidrug-resistant non-small cell lung cancer responding to TS-1].
Imai H; Sunaga N; Kaira K; Ishihara S; Aoki H; Iijima H; Yanagitani N; Iwasaki Y; Tomizawa Y; Saito R; Mori M
Gan To Kagaku Ryoho; 2007 Feb; 34(2):221-4. PubMed ID: 17301531
[TBL] [Abstract][Full Text] [Related]
38. Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line.
Nakanishi H; Mochizuki Y; Kodera Y; Ito S; Yamamura Y; Ito K; Akiyama S; Nakao A; Tatematsu M
Cancer Sci; 2003 Jan; 94(1):112-8. PubMed ID: 12708484
[TBL] [Abstract][Full Text] [Related]
39. Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.
Kim YJ; Lee HJ; Kim TM; Eisinger-Mathason TS; Zhang AY; Schmidt B; Karl DL; Nakazawa MS; Park PJ; Simon MC; Yoon SS
Int J Cancer; 2013 Jan; 132(1):29-41. PubMed ID: 22684860
[TBL] [Abstract][Full Text] [Related]
40. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Knowles HJ; Tian YM; Mole DR; Harris AL
Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
